Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice
- 31 December 1988
- journal article
- Published by Elsevier in Life Sciences
- Vol. 42 (3), 263-271
- https://doi.org/10.1016/0024-3205(88)90635-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridium (MPP+) and not blocked by deprenylLife Sciences, 1986
- Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTPEuropean Journal of Pharmacology, 1984
- Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Biochemical Pharmacology, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heartLife Sciences, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and ManCanadian Journal of Neurological Sciences, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Lowering of epinephrine concentration in rat brain by 2, 3-dichloro-α-methyl-benzylamine, an inhibitor of norepinephrine N-methyltransferaseBiochemical Pharmacology, 1977